Matthew Lang - Jul 1, 2023 Form 3 Insider Report for Lyell Immunopharma, Inc. (LYEL)

Signature
/s/ Matthew Lang
Stock symbol
LYEL
Transactions as of
Jul 1, 2023
Transactions value $
$0
Form type
3
Date filed
7/20/2023, 01:07 PM
Previous filing
Mar 10, 2023
Next filing
Aug 11, 2023

No securities are beneficially owned.